World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01841307
Date of registration: 23/04/2013
Prospective Registration: Yes
Primary sponsor: University of California, San Francisco
Public title: Cromolyn Detection of Silent Aspiration
Scientific title: Development and Validation of Test for Gastro-esophageal Reflux and Aspiration
Date of first enrolment: July 2015
Target sample size: 16
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT01841307
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  Phase 1
Countries of recruitment
United States
Contacts
Name:     Homer Boushey, MD
Address: 
Telephone:
Email:
Affiliation:  University of California, San Francisco
Key inclusion & exclusion criteria

Inclusion Criteria:

Healthy participants

- Adult non-smokers

- Females only - negative urine pregnancy test

Lung transplant patients

- Adult patients awaiting (or recently undergone) - lung transplant

- Evidence of gastro-esophageal reflux with probable recurrent aspiration

- Females only - negative urine pregnancy test

Idiopathic pulmonary fibrosis patients

- Adult patients currently enrolled in on-going University of California, San Francisco
study of prevalence of recurrent GER with aspiration in idiopathic pulmonary fibrosis

- Evidence of gastro-esophageal reflux with probable recurrent aspiration

- Females only - negative urine pregnancy test

Exclusion criteria:

Healthy participants

- History of dysphagia

- GER

- Recurrent cough

- Asthma

- Pneumonia after childhood

- Sleep impairment

- Use of drugs or alcohol impairing consciousness

- Impaired gag reflex on physical examination

- Any other significant medical illness (e.g., morbid obesity, diabetes, neurologic
disease, etc.) that in the opinion of the investigator could affect the clinical
features measured, responses to the therapies to be given in this study, or risks of
participating in the study

- Greater than 5 pack years lifetime smoking history

- History of intolerance or allergy to cromolyn sodium

Lung transplant patients

- History of intolerance or allergy to cromolyn sodium

- History of Nissen fundoplication

IPF patients

- History of intolerance or allergy to cromolyn sodium

- History of Nissen fundoplication



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Idiopathic Pulmonary Fibrosis
Gastroesophageal Reflux
Respiratory Aspiration
Lung Transplantation
Intervention(s)
Drug: Cromolyn Sodium
Primary Outcome(s)
Total cromolyn in urine collected overnight [Time Frame: Collected overnight (6 hours)]
Secondary Outcome(s)
Secondary ID(s)
13-11080
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Heart, Lung, and Blood Institute (NHLBI)
Aradign Corportation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history